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Abstract
 
RAG1 and RAG2 are the lymphocyte-specific components of the V(D)J recombinase. In vitro
analyses of RAG function have relied on soluble, highly truncated “core” RAG proteins. To
identify potential functions for noncore regions and assess functionality of core RAG1 in vivo,
we generated core RAG1 knockin (RAG1
 
c/c
 
) mice. Significant B and T cell numbers are
 
generated in RAG1
 
c/c
 
 mice, showing that core RAG1, despite missing 
 
 
 
40% of the RAG1
sequence, retains significant in vivo function. However, lymphocyte development and the
overall level of V(D)J recombination are impaired at the progenitor stage in RAG1
 
c/c
 
 mice.
Correspondingly, there are reduced numbers of peripheral RAG1
 
c/c
 
 B and T lymphocytes.
Whereas normal B lymphocytes undergo rearrangement of both J
 
H
 
 loci, substantial levels of
germline J
 
H
 
 loci persist in mature B cells of RAG1
 
c/c
 
 mice, demonstrating that DJ
 
H
 
 rearrange-
ment on both IgH alleles is not required for developmental progression to the stage of V
 
H
 
 to
DJ
 
H
 
 recombination. Whereas V
 
H
 
 to DJ
 
H
 
 rearrangements occur, albeit at reduced levels, on the
nonselected alleles of RAG1
 
c/c
 
 B cells that have undergone D to J
 
H
 
 rearrangements, we do not
detect V
 
H
 
 to D
 
H
 
 rearrangements in RAG1
 
c/c
 
 B cells that retain germline J
 
H
 
 alleles. We discuss
the potential implications of these findings for noncore RAG1 functions and for the ordered
assembly of V
 
H
 
, D
 
H
 
, and J
 
H
 
 segments.
Key words: antigen receptor • DNA cleavage • RS • hybrid joint • immune deﬁciency
 
Introduction
 
Ig and TCR variable region genes are assembled during
early lymphocyte development from component variable
(V), diversity (D), and joining (J) gene segments. V(D)J re-
combination is initiated by the RAG1 and RAG2 proteins
via introduction of DNA double strand break (DSBs) between
the V, D, and J coding segments and flanking recombination
signal (RS) sequences. RAG1 and RAG2 are necessary in
vivo and sufficient in vitro for initiation of V(D)J recombina-
tion (for review see reference 1). After DNA cleavage,
RAG-cleaved coding and RS ends are joined by ubiqui-
tously expressed, nonhomologous end-joining (NHEJ) pro-
teins (for review see reference 2).
V(D)J recombination is tightly regulated during lympho-
cyte development within the context of lymphocyte lineage
specificity, developmental stage specificity, and feedback
regulation of allelic exclusion (for reviews see references 2,
3). Furthermore, the developmental progression of lym-
phocytes requires the productive assembly and expression
of antigen receptor genes. In developing B lymphocytes, IgH
genes are assembled before IgL genes; whereas in developing
 
  
 
 T cells, TCR
 
 
 
 genes are assembled before TCR
 
 
 
genes (for review see reference 3). Both IgH and TCR
 
 
 
genes are assembled via an ordered process in which D to J
rearrangements proceed to completion on both alleles, fol-
lowed by V segment rearrangement to a preexisting DJ
complex (4, 5). Productive rearrangement and expression
of IgH 
 
 
 
 chains in ckit
 
 
 
/B220
 
int
 
/CD43
 
 
 
/CD25
 
 
 
/CD19
 
 
 
progenitor (pro–)B cells and TCR
 
 
 
 chains in CD4
 
 
 
CD8
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(double negative [DN]) pro–T cells induces cellular expan-
sion and differentiation, respectively, to the corresponding
ckit
 
 
 
/B220
 
 
 
/CD43
 
lo
 
/CD25
 
 
 
/CD19
 
 
 
 pre–B cell stage
and the CD4
 
 
 
/CD8
 
 
 
 (double positive [DP]) thymocyte
stage (6, 7). Functional rearrangement and expression of
IgL or TCR
 
 
 
 chains as part of surface IgM or 
 
  
 
 TCR
signals precursor B or T lymphocytes to develop into ma-
ture peripheral lymphocytes (for reviews see references 7, 8).
Biochemical activities of the RAG1 and RAG2 proteins
have been extensively characterized in vitro using purified
proteins and defined DNA substrates (for review see refer-
ence 9). Full-length RAG proteins are largely insoluble
when overproduced; consequently, in vitro studies have
used truncated “core” RAG proteins. Core RAG1 (aa
384–1,008 of 1,040 residues) and core RAG2 (aa 1–383 of
527 residues) comprise the minimal regions of RAG1 and
RAG2 necessary for recombination of extrachromosomal
substrates in nonlymphoid cells (10–13). Whereas core
RAGs mediate the basic V(D)J recombination reaction in
vitro, the activities of these truncated proteins are not iden-
tical to those of full-length RAGs. In this context, noncore
RAG regions influence both V(D)J recombination efficiency
and products formed when assayed in cell lines (14–19).
Noncore RAG regions are evolutionarily conserved,
suggesting these regions may serve important functions
(11). Studies of A-MuLV–transformed pre–B cells have
implicated noncore RAG regions in accessory and/or reg-
ulatory functions in chromosomal V(D)J recombination
(18, 19). Thus, NH
 
2
 
-terminal elements of RAG1 are re-
quired for complete D
 
H
 
 to J
 
H
 
 rearrangement in A-MuLV
transformants (19), whereas the COOH terminus of RAG2
may be more important for V
 
H
 
 to DJ 
 
H
 
 rearrangement than
for D
 
H
 
 to J
 
H
 
 rearrangement (18). In this regard, mice ex-
pressing core RAG2 in place of endogenous RAG2 (which
we will refer to here as RAG2
 
c/c
 
) display impaired lympho-
cyte development at the pro–B and pro–T cell stages, ac-
companied by decreased levels of V to DJ rearrangement
(20, 21). Inactivating mutations in 
 
RAG1
 
 or 
 
RAG2
 
 lead to
a complete block in lymphocyte development in mice (22,
23) and are a cause of human T
 
 
 
B
 
 
 
 SCID (24, 25). How-
ever, missense mutations in 
 
RAG1
 
 or 
 
RAG2
 
 that result in
reduced, and possibly altered, V(D)J recombinase activity
lead to Omenn Syndrome (OS), a disease characterized by
lack of B cells and a reduced, oligoclonal T cell repertoire
(24, 26). In addition, frameshift mutations in noncore
 
RAG1
 
 regions can result in NH
 
2
 
-terminal RAG1 trunca-
tions that lead to OS-like immunodeficiencies (27, 28). To
address the role of noncore RAG1 regions in vivo, we
have generated mice containing specific replacement of the
full-length endogenous 
 
RAG1
 
 gene with a gene encoding
the mouse core RAG1 protein.
 
Materials and Methods
 
Antibodies and Flow Cytometry.
 
Single cell suspensions from
lymphoid tissues were stained with antibodies conjugated to
FITC, PE, and cytochrome C (CyC) by standard procedures.
The following antibody conjugates (BD Biosciences and South-
 
ern Biotechnology Associates, Inc.) were used: CyC anti-CD44,
PE anti-CD25, CyC anti-CD4, FITC anti-CD8, FITC anti-
CD43, FITC anti-GR1, FITC anti-TCR
 
 
 
,
 
 
 
, CyC and FITC
anti-B220, and PE anti-IgM. A total of eight RAG
 
c/c
 
 mice, six
RAG
 
 
 
/c
 
, and six RAG
 
 
 
/
 
 
 
 mice between three and five wk of
age were analyzed. pro– and pre–B cell populations were sorted
based on CD43 and B220 expression after gating out all cells
staining with IgM. Cell sorting was performed on independent
BM samples from five RAG1
 
c/c
 
, one RAG1
 
 
 
/c
 
, and four
RAG1
 
 
 
/
 
 
 
 littermates.
 
Generation and Analysis of B Cell Hybridomas.
 
Single cell sple-
nocyte suspensions from RAG1
 
 
 
/
 
 
 
, RAG1
 
 
 
/c
 
, and RAG1
 
c/c
 
 mice
were cultured with anti-CD40 (1 
 
 
 
g/ml) and IL-4 (10 ng/ml) for
4 d and activated B cells fused to the NS-1 fusion partner (ATCC
TIB-18). Hybridomas were screened for isotype secretion by
sandwich ELISA using isotype-specific antibodies from SBA. Ge-
nomic DNA from each Ig-secreting hybridoma was assayed for Ig
rearrangements by Southern blotting. J
 
H
 
 rearrangement status and
the number of alleles was determined via a J
 
H
 
-specific probe on
StuI- or EcoRI-digested DNA (29). V
 
H
 
 to DJ
 
H
 
 rearrangements
were detected with a probe from 5
 
 
 
 of DFL16; V
 
H
 
 to DJ
 
H
 
 rear-
rangements will result in deletion of this fragment (hybridomas
nos. 10 and 12); whereas nonrearranged alleles or D to J
 
H
 
 rear-
ranged alleles will retain this band. DFL16 to J
 
H
 
 joins will result in
a band of unique size. Nonrearranged J
 
H
 
 alleles were confirmed by
Southern blot analyses using a probe from 3
 
 
 
 of DQ52 (30). D to
J
 
H
 
 rearrangements result in deletion of this fragment; thus, alleles
that have not undergone D
 
H
 
 to J
 
H
 
 rearrangements will retain this
germline band. Cell lines with only one detectable IgH allele orig-
inating from B cells were not further analyzed.
 
Purification of B and T Cell Fractions.
 
Single cell suspensions of
splenocytes from RAG1
 
 
 
/
 
 
 
, RAG1
 
 
 
/c
 
, and RAG1
 
c/c
 
 were cul-
tured with anti-CD40 and IL4 for B cell activation or ConA and
IL-2 for T cell activation. Activated B cells from day 2 cultures
were purified using biotinylated anti-CD19–specific antibodies in
conjunction with streptavidin-conjugated MACS microbeads and
MACS Separation Columns (Miltenyi Biotech). T cells cultured
with ConA 
 
  
 
IL-2 for 6 d were purified by Lympholyte-M sedi-
mentation (Cedarlane). Purity of separated B and T cells was ana-
lyzed by flow cytometry and found to be at least 90%. DP T cell
DNA was isolated by staining thymocytes with FITC anti-CD4
and PE anti-CD8 antibodies and sorting on a MO-Flo (Becton
Dickinson). DN3 thymocyte DNA was isolated by first depleting
CD4
 
 
 
 thymocytes using anti-CD4-conjugated MACS micro-
beads and staining the unbound cell fraction with CYC anti-
CD44, PE anti-CD25, and a combination of FITC anti-CD4,
-CD8, -B220, -Mac1, -GR1, and -TCR
 
 
 
,
 
 
 
 antibodies and sort-
ing on live-gated FITC
 
 
 
, CYC
 
 
 
, and PE
 
 
 
 cells.
 
PCR Analysis of IgH and TCR Rearrangements.
 
Genomic
DNA from sorted pro– and pre–B cell populations and purified
CD4
 
 
 
CD8
 
 
 
 DP or CD4
 
 
 
CD8
 
 
 
CD44 CD25  DN3 T cells was
analyzed for IgH and TCR  rearrangements by PCR amplifica-
tion (31, 32). LMPCR for SE breaks were performed as de-
scribed previously (33). Oligos and PCR primers are listed in
Table S1 (available at http://www.jem.org/cgi/content/full/
jem.20030627/DC1). Briefly, PCR reactions contained 90, 30,
10, and 3.3 ng or 250, 50, 10 and 2 ng of genomic DNA for IgH
and TCR  amplifications, respectively, 20 pmol of each primer,
0.2 mM dNTPs, 50 mM KCl, 10 mM Tris-HCl (pH 8.0), 2.5
mM MgCl2, and 0.5 U QIAGEN Taq polymerase. Amplification
conditions were as follows: 94 C for 45 s, 60 C for 1 min, 72 C
for 2.5 min for 30 cycles. Amount of input genomic DNA was
normalized by PCR amplification of a coding exon of the ATMT
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gene. PCR products were analyzed by agarose gel electrophore-
sis, transferred to Zetaprobe membrane, and probed with nested
oligonucleotide probes to detect rearrangements. PCR analyses
were performed at least three times on genomic DNA samples
from sorted B cells and purified T cells, respectively, isolated from
at least three RAG1c/c mice and either RAG1 /c or RAG1 / 
littermates.
Generation of Core RAG1 Mice. The pMS127 plasmid con-
taining the core RAG1 coding sequence and three copies of a
human c-Myc tag at the COOH-terminal end was provided by
M. Sadofsky (Albert Einstein College of Medicine) (11). The
core RAG1 coding sequence contains a single nucleotide change
(A to G) that results in a methionine to valine substitution at po-
sition 484. A similar form, with an additional 9-residue Histidine
COOH-terminal tag, has been used extensively in vitro to define
the biochemical and V(D)J recombination activities intrinsic to
the RAG recombinase (34–36) 2.1 kb of homologous sequence
immediately 5  of RAG1 was cloned along with core RAG1
coding sequence into the SalI site of pLNTK (37). A 3.3-kb MluI
to BamH1 fragment was cloned into the XhoI site to complete
the core RAG1 replacement vector. TC1 embryonic stem cells
(provided by P. Leder, Harvard Medical School) were transfected
with the targeting vector as described previously (38). A posi-
tively selected recombinant was identified by Southern blotting
using the 5  and 3  targeting probes (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20030627/DC1). The LoxP
flanked neomycin resistance (Neor) gene was deleted by tran-
siently transfecting the ES cell clone with a plasmid-based Cre re-
combinase expression construct (37). Subclones of this ES cell
line were injected into C57Bl/6 blastocysts to generate chimeric
mice. RAG1 /c mice were intercrossed to produce 129sv
RAG1c/c mice.
Results
The Generation of Mice that Express the Core RAG1 Pro-
tein. To evaluate in vivo functions of noncore RAG1 re-
gions, we used gene targeting to replace the endogenous
RAG1 gene with a recombinant gene encoding the mouse
Figure 1. Flow cytometric analysis of T cell development in
RAG1c/c mice. (A) FACS® analysis was performed on thy-
mocytes isolated from RAG1c/c, RAG1 /c, and RAG1 / 
littermates stained with CyC anti-CD4 and PE anti-CD8. (B)
Double negative thymocytes stained with PE anti-CD44 and
FITC anti-CD25 after electronically gating out CD4, CD8,
TCR , , B220, and GR-1 positively staining cells. (C) Spleno-
cytes  from RAG1c/c, RAG1 /c, and RAG1 /  littermates
were stained with CyC anti-CD4 and PE anti-CD8 antibodies.
(D) Thymocytes were stained with FITC anti-TCR  after
electronically gating on CD4 CD8  DP cells. Mice were
analyzed at 3–5 wk of age; representative data are shown. Total
thymus cell counts are indicated over the panels in A, and total
spleen cell counts are indicated over the panels in C.T
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core RAG1 protein (aa 384–1008) (Fig. S1, available at
http://www.jem.org/cgi/content/full/jem.20030627/DC1).
We first generated targeted ES clones with endogenous
RAG1 replaced on a single allele by the synthetic core
RAG1 gene and a 3 loxP-PGK-Neor cassette (Fig. S1, A
and B). We then used transient expression of Cre recombi-
nase to delete the PGK-Neor cassette (Fig. S1 B). Chimeric
mice from Cre-deleted ES cell clones were bred to 129sv
mice to obtain mice carrying the core RAG1 gene in their
germline. Heterozygous core RAG1 (RAG1 /c) mice were
intercrossed to produce RAG1c/c mice and RAG1 /c and
RAG1 /  littermate controls (Fig. S1 C). The core RAG1
protein was expressed at elevated levels compared with the
full-length protein, as predicted by previous studies (13,
15), and was found mostly in nuclear extracts (Fig. S1 D).
RAG1c/c mice were housed in a pathogen-free environ-
ment and survived into adulthood without overt defects.
Core RAG1 Mice Exhibit Impaired Lymphocyte Develop-
ment. We found reduced thymic cellularity of RAG1c/c
mice compared with RAG1 /c and RAG1 /  control
mice (average thymocyte count for RAG1c/c thymuses  
29%     11% of controls; Fig. 1 A). FACS® analyses of
RAG1c/c thymocytes demonstrated an almost normal dis-
tribution of CD4 /CD8  (DP) and CD4 /CD8  or
CD4 /CD8  (single positive) populations (Fig. 1 A).
However, RAG1c/c mice accumulated CD4 /CD8  (DN)
pro–T cells with a strikingly high percentage of cells amass-
ing at the CD25 CD44  (DN3) stage compared with
RAG1 /c and RAG1 /  control mice (Fig. 1 B). TCR 
rearrangements are completed within the DN3 stage, with
productive TCR  expression inducing cellular prolifera-
tion, differentiation to the CD25 CD44  DN4 stage, and
cessation of further V  to DJ  rearrangement (allelic ex-
clusion) (for review see reference 39). Thus, the accumula-
tion of RAG1c/c DN3 thymocytes is consistent with di-
minished capacity of core RAG1 to efficiently mediate
complete V DJ  rearrangements.
TCR  chain expression is not required for the DN to
DP transition (for reviews see references 7, 39). However,
we found an increased ratio of TCR lo to TCR int DP
thymocytes in RAG1c/c mice compared with controls (Fig.
1 D). This is consistent with delayed TCR  rearrange-
ment, since DP thymocytes from mice that lack either the
TCR  enhancer or TCR  genes likewise express low lev-
els of TCR  at their cell surface in the absence of TCR 
chains (40, 41). We did not detect TCR   DP thymocytes
in RAG1c/c mice, confirming that delayed development
due to decreased V(D)J recombination efficiency does not
allow progression to the DP stage in the absence of TCR 
gene expression (Fig. 1 D). The absolute numbers of
splenic    T cells in RAG1c/c mice were reduced  50%
from that of RAG1 /c and RAG1 /  controls (Fig. 1 C).
We conclude that overall T cell development in RAG1c/c
mice is impaired with respect to the pro– to pre–T cell
transition, accompanied by a modest reduction in overall T
cell numbers.
We detected a statistically significant reduction in the
percentage and absolute number of CD43loB220  pre–B
cells in RAG1c/c mice relative to RAG1 /c and RAG1 / 
control mice (average pre–B cell count RAG1c/c BM  
6.5   2.9   105 versus 10.3   1.3   105 in control litter-
mates, P   .020 by paired t test; Fig. 2 A) (6). Correspond-
ingly, the absolute splenic B cell numbers in RAG1c/c mice
were  50% of those in control mice (Fig. 2 C). On the
other hand, absolute BM CD43 B220int pro–B cell num-
bers were relatively normal in RAG1c/c mice (average pro–B
cell count RAG1c/c BM   5.2   1.7   105 versus 5.5  
1.5   105 in control littermates); and the percentages of
Hardy fractions D, E, and F in the BM of RAG1c/c and lit-
termate controls were also comparable (Fig. 2, A and B)
(6). Therefore, B cell development in RAG1c/c mice shows
a modest impairment in the pro– to pre–B cell transition
and a corresponding reduction in overall B cell numbers.
TCR  and TCR  Gene Rearrangements in RAG1c/c
Mice. Since RAG1c/c mice exhibit impaired T cell devel-
opment, we assayed for potential alterations in TCR  rear-
rangement. We employed PCR primers located 5  of D 1
or D 2 and 3  of J 1 or J 2 to amplify D 1 to J 1 and
D 2 to J 2 rearrangements from purified CD44 CD25 
DNIII or DP thymocytes from RAG1c/c and control mice
Figure 2. Flow cytometric analysis of B cell development in RAG1c/c
mice. (A) FACS® analysis was performed on RBC-free BM cells isolated
from both femurs of individual RAG1c/c, RAG1 /c, and RAG1 /  litter-
mates stained with CyC anti-B220, FITC anti-CD43, and PE anti-IgM
antibodies and gated on the IgM  population. B220intCD43  pro–B and
B220 CD43lo pre–B cell populations are shown. (B) B220 CD43lo BM
cells were further stained with PE anti-IgM to determine the percentage
of BM cells in Hardy fractions D, E, and F. (C) Splenocytes from RAG1c/c,
RAG1 /c, and RAG1 /  littermates were stained with CyC anti-B220
and PE anti-IgM antibodies. Mice were analyzed at 3–5 wk of age; repre-
sentative data are shown. Total spleen cell counts are indicated over the
bottom panels.T
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(32). The levels of PCR products representing most D 1
to J 1 rearrangements were reduced in DNA isolated from
DN3 T cells of RAG1c/c mice compared with controls
(Fig. 3 A). Similarly, D 2 to J 2 levels were reduced and
were accompanied by increased levels of germline D 2/
J 2 bands (Fig. 3 A). In contrast, D 1 to J 2 rearrange-
ment levels were comparable between RAG1c/c and con-
trol mice (Fig. 3 A). We found a similar reduction in D 1
to J 1 and D 2 to J 2 rearrangements in DNA isolated
from sorted RAG1c/c DP thymocytes, but D 1 to J 2 re-
arrangements again were not markedly changed (Fig. S2
A, available at http://www.jem.org/cgi/content/full/jem.
20030627/DC1). There was also a diminished level of 3 
D  broken RS ends in DN3 thymocyte DNA from
RAG1c/c mice, consistent with reduced RS cleavage by
core RAG1 (Fig. 3 C).
We employed V 8- and V 10-specific primers in con-
junction with 3  J  1 or 3  J  2 primers to determine
whether V  rearrangement is altered in RAG1c/c versus
WT mice. V 8 and V 10 rearrangements to either J 1 or
J 2 were dramatically reduced in RAG1c/c DN3 thy-
mocytes (Fig. 3 B). Likewise, 5 D  RS ends were also
reduced in RAG1c/c DN3 thymocytes, consistent with
reduced RAG-mediated cleavage during V  to DJ  rear-
rangement (Fig. 3 C). Conversely, there was little or no
reduction in V 8 or V 10 to J 2 rearrangements in
RAG1c/c DP thymoyctes (Fig. S2, A and B), as expected
given selection for at least one (productive) V (D)J  rear-
rangement in each DP cell. Therefore, the ability of core
RAG1 to mediate TCR  rearrangements in vivo appears
compromised for both the D  to J  and V  to DJ  steps.
In WT mice, TCR  genes rearrange on both alleles during
the DP T cell stage; thus, all mature T cells will have de-
leted the sequences located between the 3  most V  and 5 
most J  segments (42). Southern blot analysis using a probe
from between V  and J  gene segments (probe 8) (40)
demonstrated that both TCR  alleles rearrange to comple-
tion in mature T cells of RAG1c/c and WT mice (Fig. 3
D). Although this finding does not rule out a modest re-
duction in TCR  rearrangement in RAG1c/c DP cells, it
shows that overall TCR  gene rearrangements are not sub-
stantially altered.
Figure 3. TCR  rearrangements. Genomic DNA from sorted CD44 CD25  DN3 T cells or nonrearranged control tissue (kidney) from RAG1 / 
and RAG1c/c mice was isolated and subjected to PCR amplification of D to J 1 and D to J 2 (A) and V to DJ 1 and V to DJ 2 (B) rearrangements.
PCR amplification was performed on serial fivefold dilutions of genomic DNA, and the products were detected by Southern blot hybridization. Control
PCR amplification of a nonrearranging locus was also performed to normalize levels of input DNA. (C). LMPCR was used to detect RS broken signal
ends from 5  D 1, 3  D 1, 5  D 2, and 3  D 2 in DNA of sorted DN3 thymocytes isolated from RAG1c/c and RAG1 /  mice as described previously
(21, 63). Fivefold serially diluted linker ligated DNA is shown along with a PCR reaction of a nonrearranging locus as a loading control. (D). Southern
blot analysis on Eco0109-digested DNA isolated from spleen of purified day 6 ConA   IL-2 activated splenic T cells to determine the extent of TCR 
rearrangement as described previously (40).T
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Rearrangements of IgH and Ig  in RAG1c/c Mice. We
used a PCR approach to analyze DH to JH and VH to DJH
rearrangements in sorted CD43 B220int pro–B and
CD43loB220  pre–B cells of RAG1c/c and control mice.
Normal B cells usually rearrange DH to JH on both IgH al-
leles (4, 6). Moreover, all pre–B cells, based on selection for
IgH   chain expression, will have a productive VHDJH re-
arrangement on one of their two JH alleles (43). Approxi-
mately 40% of normal mature B cells have a nonproductive
VHDJH rearrangement on their second nonselected allele,
with the remaining  60% having a DJH rearrangement on
the second nonselected allele (4). Therefore, the overall
level of VH to DJH rearrangements can be reduced by, at
most,  30% in pre–B or mature B cell populations. Con-
sequently, PCR methods cannot accurately quantify the ef-
fects on VH to DJH rearrangement in these populations.
However, PCR can be used to assay for overall reduction
in the level of DH to JH recombination, which would be
reflected by increased levels of germline alleles.
We employed PCR primers located 5  of DHQ52 and 3 
of the JH4 gene segment to amplify DHQ52 to JH rear-
rangements. Assembled DHQ52JH complexes can be ex-
cised from the chromosome upon subsequent rearrange-
ment of 5  DH segments with 3  JH gene segments (44, 45).
Therefore, the use of a 3  primer downstream of JH4 per-
mits specific amplification of DHQ52 to JH rearrangements
retained within the IgH locus on alleles that lack VH to DJH
rearrangements. Joining of DHQ52 to JH segments, espe-
cially JH4, was reduced in both RAG1c/c pro–B and pre–B
cells (Fig. 4 A). Consistent with reduced DJH joining, we
observed increased levels of germline JH alleles, most nota-
bly in the pre–B cell population (Fig. 4 A). We conclude
that RAG1c/c pro–B and pre–B cells have reduced levels of
DHQ52 to JH rearrangements. To examine other DH seg-
ments, we employed a degenerate 5  DH RS primer (31) to
amplify most DH to JH rearrangements. The level of DH to
JH1 and JH4 rearrangements also was reduced in both
RAG1c/c pro– and pre–B cells, but DH rearrangements to
JH2 and JH3 were present at control levels (Fig. 4 A). Nota-
bly, the level of 3  DFL16 RS ends did not appear to be
markedly reduced in RAG1c/c pro–B cells (Fig. 4 D).
We also analyzed rearrangement of three frequently used
VH gene segment families (VH7183, VHQ52, and VH558) in
RAG1c/c B lineage cells. We employed a 3  J H4 primer
along with 5  primers specific to these VH families to am-
plify family-specific VHDJH rearrangements (31). Rear-
rangement of all three VH families were reduced in RAG1c/c
pro–B cells (Fig. 4 B). However, in RAG1c/c pre–B cells,
Figure 4. IgH rearrangements.
Genomic DNA from sorted pro–
and pre–B cell populations from
RAG1 /  and RAG1c/c littermates
was isolated and subjected to PCR
amplification of D to JH (A), V to
DJH (B), and V  to J (C) rearrange-
ments. PCR amplification was per-
formed on serial threefold dilutions
of genomic DNA, and the products
were detected by Southern blot hy-
bridization. Control PCR amplifica-
tion of a nonrearranging locus was
also performed to normalize levels of
input DNA. One of four experi-
ments performed on independent
sets of sorted B cell samples is
shown. (D). LMPCR was used to
detect RS broken signal ends from
the indicated RSSs in DNA of
sorted pro– and pre–B cells isolated
from RAG1c/c and RAG1 /  mice
as described previously (21, 63).
Fivefold serially diluted linker ligated
DNA is shown along with a PCR
reaction of a nonrearranging locus as
a loading control.T
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rearrangements of these same VH families were only mod-
estly reduced (Fig. 4 B). As outlined above, this is not sur-
prising because all pre–B cells will have at least one produc-
tive VHDJH rearrangement. Overall utilization of tested VH
families in pro– or pre–B cells was not dramatically altered
(Fig. 4 B), indicating that, at least at a gross level, usage of
endogenous VH families by core RAG1 is not obviously in-
fluenced by RS sequence [RSS] or VH chromosomal loca-
tion. We also detected a reduction in the level of 5 DFL16
and 5 DQ52 RS ends in the DNA of pro–B cells, indicat-
ing a reduced capacity of core RAG1 to mediate VH to DJH
RS cleavage compared with full-length RAG1 (Fig. 4 D).
Therefore, RAG1c/c pro–B cells have reduced overall levels
of VHDJH rearrangements but relative utilization of differ-
ent VH families is not markedly altered.
To analyze Ig  rearrangements, we performed PCR
analyses on DNA isolated from sorted pro– and pre–B cells
using a V -specific primer in conjunction with a primer lo-
cated downstream of J 4. We detected equivalent levels of
V  to J  rearrangements in pre–B cells of RAG1c/c and
control mice, indicating that the noncore regions of RAG1
are not required for accumulation of normal levels of V  to
J  rearrangements (Fig. 4 C). We also found an equivalent
level of 5  J 1 RS ends in pre–B cells of RAG1c/c and con-
trol mice, consistent with the finding that V  to J  rear-
rangements are not substantially diminished (Fig. 4 D).
Mature B Cells with Germline JH Alleles in RAG1c/c Mice.
Normally, DH to JH rearrangement occurs on both IgH al-
leles in developing pro–B cells before the onset of VH to
DJH rearrangement (6). However, our PCR analyses sug-
gested possible retention of germline JH alleles in RAG1c/c
pre–B cells. To confirm this, we performed Southern blot
analyses on genomic DNA from purified CD19  splenic B
cells of RAG1c/c and control mice using a JH-specific
probe. Whereas RAG1 /  B cells had, as expected, little or
no unrearranged JH loci, RAG1c/c B cells contained a sub-
stantial level of the germline-sized JH fragment (Fig. 5 and
not depicted). To more precisely quantify the reduction in
JH rearrangements on the nonproductive allele in RAG1c/c
B cells, we analyzed JH rearrangements in B cell hybrid-
omas. Previous analyses have shown that a low percentage
of hybridomas from WT mice retain germline JH alleles (4,
30), despite the fact that essentially no germline JH locus is
detectable in purified splenic B cells (4, 46). These findings
suggested that WT hybridomas with germline JH alleles
most likely result from tripartite fusions involving non–B
lineage cells. Consistent with prior studies (30), Southern
blot analyses revealed that most control hybridomas had re-
arrangements of both JH alleles; although a few retained a
germline-sized band (Table I). In dramatic contrast, 59% of
the RAG1c/c B cell hybridomas contained a germline JH al-
lele (Fig. 5, A and C; Table I). This very high level of re-
tained germline JH alleles in RAG1c/c B cell hybridomas
confirms the findings with purified CD19  B cells (Fig. 5
and not depicted). Therefore, expression of core RAG1
in the absence of WT RAG1 results in a developmentally
altered pattern of IgH locus rearrangement in which VH
to DJH rearrangements frequently occur in developing
Figure 5. IgH rearrangement status in RAG1c/c B cell hybridomas. Genomic DNA was isolated from RAG1c/c hybridoma cell lines shown to secrete Ig,
and the rearrangements were examined by Southern blot analysis. (A). Southern blot analysis of hybridoma DNA using a JH-specific probe on StuI-digested
DNA for determining JH rearrangement status. (B). Southern blot analysis of hybridoma DNA using a 5  DFL16-specific probe on EcoR1-digested
DNA for determining VH to DJH rearrangement status. (C). Southern blot analysis of hybridoma DNA using a 3  DQ52-specific probe on Stu1-
digested DNA for confirming germline IgH rearrangement status. Arrows indicate two hybridomas with VHDJH rearrangements on both IgH alleles. The
presence of two IgH alleles was confirmed by Southern blot hybridization with the JH probe on EcoR1-digested DNA. Representative data are shown.T
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RAG1c/c B lineage cells that have not yet completed DH to
JH rearrangement on both alleles.
To determine the level of VHDJH versus DJH rearrange-
ments on the rearranged nonselected JH allele of RAG1c/c B
lineage cells, we also quantified the number of DJH and VH-
DJH rearrangements in RAG1c/c and control B cell hybrid-
omas. Southern blotting with a probe that hybridizes be-
tween the VH and DH gene segments demonstrated that 26
out of 42 (62%) and 12 out of 42 (28%) of the second alleles
contained, respectively, DJH and VHDJH rearrangements in
control B cell hybridomas (Table I). In contrast, whereas the
majority of RAG1c/c B cell hybridomas contained one allele
in germline configuration, the remaining 23 out of 66 (35%)
and 4 out of 66 (6%) of the nonproductive alleles contained,
respectively, DJH and VHDJH rearrangements (Fig. 5 and
Table I). Therefore, there is a significant reduction in the
percentage of RAG1c/c B cells containing VH to DJH rear-
rangements on the nonproductive allele.
All RAG1c/c B cell hybridomas with germline JH loci also
contained hybridizing sequences between the most JH-
proximal VH gene segment and the most 5  DH gene seg-
ment (Fig. 5 C and Table I) (30), indicating lack of direct
VH to DH rearrangements. In addition, we were unable to
amplify direct VH to DH rearrangements in WT or RAG1c/c
pro– or pre–B cell populations by PCR using sets of prim-
ers designed to amplify rearrangements involving the three
VH gene segment families VH558, VH7183, and VHQ52 and
either DFL16 or DQ52 gene segments (unpublished data).
Similarly, using an upstream VH81X primer in conjunction
with the DHR primer that anneals to the 3  RS sequence of
DSP and DFL gene segment families (31), we were unable
to amplify direct VH81X to DH rearrangements (unpub-
lished data). Thus, despite the notable reduction in DH to JH
rearrangement, none of the RAG1c/c B lymphocytes ap-
peared to have undergone direct VH to DH rearrangements
on the nonselected second allele (Fig. 5 and Table I).
Therefore, RAG1c/c mice exhibit a marked impairment in
both DH to JH and VH to DJH rearrangement.
RAG1c/c Mice Exhibit an Increased Level of DH to JH Inver-
sional Hybrid Joints. We used a PCR strategy to compare
the levels of normal and hybrid inversional DH to JH
joints (DJHinv) between RAG1c/c and control mice (Fig.
S3, available at http://www.jem.org/cgi/content/full/
jem.20030627/DC1). Previous studies have shown that
DJHinv joints occur in WT mice at levels  3 logs lower
than normal DH to JH joints (47). Primary amplifications of
DJHinv joints in DNA isolated from pro– and pre–B cells
of both WT and RAG1c/c mice revealed an approximate
three to fivefold increase in the levels of DJHinv joints de-
tected in the latter (Fig. S3). To confirm that the amplified
products observed were in fact the products of DJHinv rear-
rangements, we cloned and sequenced the junctions of 14
unique WT and 35 unique RAG1c/c DJHinv joints (Fig.
S4, available at http://www.jem.org/cgi/content/full/
jem.20030627/DC1). Consistent with previous studies
(47), we estimate 13 of the 14 DJHinv joints cloned from
WT mice and 31 out of 35 from RAG1c/c mice were hy-
brid joints (HJ), with the remainder likely being DJHinv
coding joints (Fig. S4). These HJs form when the 23-bp
RS previously associated with a JH gene segment becomes
juxtaposed to a DH-coding gene segment originally associ-
ated with a 12-bp RS, albeit in an inverted orientation
(Fig. S3) (47). The junctions of HJs isolated from both WT
and RAG1c/c mice frequently displayed a loss in DH coding
sequence, and all but four of the RAG1c/c clones had P or
N nucleotide additions (Fig. S4).
Discussion
Altered V(D)J Recombination in RAG1c/c Mice. We dem-
onstrate that lymphocyte development and V(D)J recombi-
nation is modestly reduced in mice that express the core
RAG1 protein in place of the WT RAG1 protein. The oc-
currence of significant levels of lymphocyte development
in RAG1c/c mice is in accord with findings that the RAG1
core protein maintains substantial levels of cleavage activity
in vitro. Thus, nearly 40% of the highly conserved RAG1
protein is not required to access RSSs and initiate V(D)J re-
combination in the context of chromosomal DNA. In ad-
dition, noncore regions of RAG-1 are not absolutely nec-
essary for recruitment of factors required to complete the
V(D)J recombination reaction in vivo. Moreover, the ab-
Table I. IgH Status of Hybridomas Derived from Rag1+/+ or Rag1c/c B Cells
Genotype Experiment V(D)J/DJ V(D)J/V(D)J V(D)J/germline Total
(%) (%) (%)
RAG+/+ Fusion 1 14 (61) 7 (30) 2 (9) 23
Fusion 2 7 (64) 3 (27) 1 (9) 11
Fusion 3 5 (63) 2 (25) 1 (12) 8
Total 26 (63   2) 12 (27   3) 4 (10   2) 42
RAG1c/c Fusion 1 7 (33.3) 1 (4.8) 13 (61.9) 21
Fusion 2 12 (32.4) 2 (5.4) 23 (62.2) 37
Fusion 3 4 (50) 1 (12.5) 3 (37.5) 8
Total 23 (38.6   9.9) 4 (7.6   4.3) 39 (53.9   14.2) 66T
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solute numbers of prolymphocytes are not as substantially
reduced in RAG1c/c mice, as is found in NHEJ-deficient
mice, suggesting that DNA DSBs initiated by the core
RAG1 protein are properly repaired (48, 49). However,
we cannot rule out a modest diminution in joining activi-
ties. Overall, RAG1c/c mice clearly exhibit an impairment
in both B and T cell development at the pro to prelympho-
cyte transition, the same stage at which RAG1- (and
RAG2-) deficient mice exhibit a complete developmental
block (22, 23).
In normal mice, D to J rearrangements take place on
both TCR  or IgH alleles before V to DJ rearrangement
(4–6). However, RAG1c/c mice develop mature lympho-
cytes with germline JH loci on their nonproductive alleles,
indicating that the noncore regions of RAG1 are required
for fully efficient D to J rearrangement. Retention of germ-
line JH loci occurs despite the fact that DH to JH rearrange-
ment initiates at an earlier developmental stage than VH to
DJH rearrangement (6). Expression of core RAG1 in the
absence of WT protein also results in a reduced frequency
of VHDJH rearrangements on nonselected alleles that con-
tain DJH rearrangements. Therefore, reduced frequency of
both DJH and VHDJH rearrangements on the nonselected
alleles in RAG1c/c mice likely reflects a decrease in overall
V(D)J recombination efficiency. The decreased levels of 3 
D  RS ends, which are associated with D to J rearrange-
ments, along with the decreased levels of 5  DH and 5  D 
RS ends, which are associated with V to DJ rearrange-
ments, further supports this conclusion. Of note, previous
studies showed that Ig  and TCR  rearrangements were
not reduced in RAG2c/c mice (20, 21) which was argued
to reflect a correlation between recombination efficiency
and specific RS sequence motifs (21). In this regard, we
also find that V  to J  rearrangements are comparable be-
tween RAG1c/c and control mice and that the TCR  locus
rearranges on both alleles of RAG1c/c T cells.
Although the above findings clearly demonstrate that
overall V(D)J recombination is affected in RAG1c/c mice at
the IgH and TCR  loci, we cannot unequivocally rule out
the possibility of more subtle effects of truncated core
RAG1 on D to J versus V to DJ rearrangements. Notably,
expression of core RAG1 in place of full-length RAG1 re-
sulted in the same or even increased production of DJHinv
hybrid joints suggesting that noncore regions of RAG1
may preferentially favor this form of hybrid D to J join. In
this regard, it is possible that the noncore region of RAG1
may contribute to the proper assembly or stability of synap-
tic and/or postcleavage complexes, thereby increasing
overall recombination efficiency while leading to a de-
creased frequency of aberrant recombination products. This
would be consistent with previous studies showing an in-
creased frequency of hybrid joins and transposition events
by core RAGs (17, 50, 51). However, we note that we
cannot rule out the possibility that the steady-state increase
in DJHinv hybrid joins results from a decreased level of sec-
ondary DJH joins that would delete such rearrangements in
normal preB cells.
VH to DJH and V  to DJ  rearrangements were dramati-
cally reduced in developing lymphocytes of mice that ex-
press core RAG2 in place of full-length RAG2 (20, 21).
One study concluded that D to J recombination at the IgH
and TCR  loci was unaffected in core RAG2-expressing
mice and showed that the reduction in V to DJ rearrange-
ment correlated with decreased RAG cleavage activity at
the 5  D and V RSSs (21). A separate study found a similar
effect on V to DJ rearrangements but clearly demonstrated
through direct hybridoma analyses that DH to JH rearrange-
ment was also impaired in core RAG2-expressing mice
(20). However, VHDJH rearrangements on nonselected al-
leles were not detected in core RAG2-expressing B cell hy-
bridomas, suggesting that the homozygous core RAG2 mu-
tation affects VH to DJH rearrangement more substantially
than DH to JH rearrangement (20, 21). In contrast, we have
demonstrated VHDJH rearrangements do occur on nonse-
lected alleles of RAG1c/c B cell hybridomas and find that re-
duction in D to J and V to DJ rearrangements are accompa-
nied by reduced cleavage at both 5  and most 3  D RSSs.
Implications of Altered V(D)JH Rearrangement Patterns in
RAG1c/c B Lineage Cells. Ordered assembly of IgH and
TCR  genes appears to be mediated through developmen-
tal stage-specific D versus V segment accessibility (4, 52).
Our detection of mature B cells with nonrearranged IgH
alleles demonstrates that the expression of core RAG1 in
place of full-length RAG1 allows developing B cells to
progress to a stage in which VH to DJH rearrangement can
take place in the absence of DJH rearrangements on both
alleles. Thus, these studies indicate that there is no mecha-
nistic requirement for DH to JH rearrangement on both al-
leles for progression to a developmental stage in which VH
gene segments become accessible. However, we did not
detect direct VH to DH joins in the absence of DJH rear-
rangements in the RAG1c/c B cells. Although absence of
direct VH to DH joins might be explained by recombina-
tional efficiency, it would also be consistent with a mecha-
nistic requirement for a DH to JH deletional rearrangement
before a subsequent VH to DJH rearrangement on the same
allele. If so, VH to DJH rearrangement may require deletion
of sequences between DHQ52 and the JH1 gene segment
and/or be specifically targeted only to an assembled DJH
complex versus a nonrearranged upstream germline DH
segment. Thus, rearrangement may allow establishment of
VH gene accessibility, for example, by activating the 5  DH
RSS via the germline DH promoter, or may facilitate the
capture or synapsis of VH-associated RS target sequences.
In the latter context, it is notable that deletion of the 3  D 
RSS allowed direct V  to D  joining in the absence of D 
to J  joining (53), suggesting that the 3  D  RSS may be
responsible for maintaining ordered rearrangement, perhaps
by providing a high affinity RAG binding site.
Putative Functions of Noncore RAG1 Regions. The NH2
terminus of RAG1 contains a zinc finger ring domain in-
volved in homodimerization (54) and cysteine-containing
elements with suggested multimerization functions (19).
The ring finger domain has E3 ubiquitin ligase activity, al-T
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though a physiological function has yet to be linked to this
activity (55). In addition, three basic regions within the
NH2 terminus of RAG1 associate with SRP1 (56), a pro-
tein known to interact with nuclear localization sequences
and to be involved in facilitating nuclear transport (57). Al-
though mutations in these basic regions affect binding to
SRP1, nuclear localization is not dramatically altered be-
cause there are additional nuclear localization sequences
within the RAG1 core region (56). In this regard, we show
that core RAG1 is expressed at somewhat higher levels
than WT RAG1, with the majority of protein being lo-
cated in the nucleus. Elevated expression of core RAG1
compared with full-length RAG1 probably reflects the de-
letion of sequences regulating its degradation (13, 16, 19).
The observation that both DJH and VHDJH rearrange-
ments are affected in RAG1c/c mice suggests the core
RAG1 protein simply may be inefficient at mediating
V(D)J recombination. Likewise, our PCR analyses indicate
that the relative efficiencies of certain V  to DJ  rear-
rangements in RAG1c/c DP T cells is very similar to that of
core RAG2-expressing T cells (21). In this context, the
modest reduction in peripheral lymphocyte numbers prob-
ably reflects a selection and expansion of the few B and T
cells that productively rearrange their antigen receptor
genes. Although the nature of the V(D)J recombination
defect is unclear, one could speculate that multimerization
motifs within the noncore regions of RAG1 could be im-
portant for synapsis between cleavage complexes and/or
other proteins associated with distant RS/coding gene seg-
ments, with early disassembly of the cleavage complex oc-
curring in their absence. E3 ubiquitin ligases have been
linked to protein degradation, cell cycle control, and DNA
repair (58) and that such an activity is contained within the
NH2-terminal region of RAG1 raises some intriguing pos-
sibilities. For instance, it was shown recently that RAG2 is
targeted for degradation by ubiquitination (59). Ubiquiti-
nation mediated by RAG1 could ensure that a RAG-asso-
ciated complex is disassembled and removed from coding
gene segments to allow for efficient ligation by NHEJ pro-
teins. Another possibility would be that RAG1-dependent
ubiquitination of histones flanking RAG-initiated DSBs
may alter chromatin structure to facilitate subsequent repair
(55, 60).
RAG Mutations and Immune Deficiencies. Mutations in
both RAG1 and RAG2 can result in partial recombination
activity that in humans can lead to T B  SCID and OS.
One group of frameshift mutations identified in OS and
OS-like patients leads to alternative ATG usage resulting in
NH2-terminally truncated RAG1 proteins (27, 28). In
vitro experiments demonstrated that, like the core RAG1
protein, proteins encoded by these frameshift mutant alleles
remain partially functional for V(D)J recombination; how-
ever, in vivo they lead to dramatically reduced lymphocyte
numbers and to immune deficiency (27, 28). Although the
NH2-terminal truncation of the murine core RAG1 pro-
tein does not fully recapitulate the effects of the frameshift
mutant alleles detected in these OS patients, RAG1c/c mice
do exhibit some similar phenotypes. For example, germline
D -J  sequences have been isolated from the T cells of OS
patients, demonstrating incomplete TCR  rearrangement
(61). The targeted core RAG1 replacement results in the
deletion of a larger stretch of NH2-terminal sequences than
the human frameshift mutations. Yet RAG1c/c mice have
only slightly reduced numbers of B and T lymphocytes
compared with OS patients that have variable T cell num-
bers but virtually undetectable B cells (26, 62). Many hu-
man RAG1 frameshift mutations result in decreased pro-
tein expression and cellular mislocalization (27), but core
RAG1 in RAG1 /c mice is expressed at levels higher than
that of full-length RAG1 protein and is expressed predom-
inantly in the nucleus. Therefore, development of OS in
patients with NH2-terminal frameshift mutations may not
simply be due to the absence of the noncore RAG1 regions
but may also be influenced by reduction in the overall
amount or localization of the truncated RAG1 protein.
The generation of mice harboring mutations in RAG1 that
directly mimic those found in human OS patients should
provide insights into the relationship between RAG activ-
ity and the development of specific immune deficiencies.
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